Objective: To investigate the use of quantitative EEG (qEEG) in patients with acute encephalopathies (AEs) and EEG background abnormalities. Method: Patients were divided into favorable outcome (group A, 43 patients) and an unfavorable outcome (group B, 5 patients). EEGLAB software was used for the qEEG analysis. A graphic of the spectral power from all channels was generated for each participant. Statistical comparisons between the groups were performed. Results: In group A, spectral analysis revealed spectral peaks (theta and alpha frequency bands) in 84% (38/45) of the patients. In group B, a spectral peak in the delta frequency range was detected in one patient. The remainder of the patients in both groups did not present spectral peaks. Statistical analysis showed lower frequencies recorded from the posterior electrodes in group B patients. Conclusion: qEEG may be useful in the evaluations of patients with AEs by assisting with the prognostic determination.
Acute encephalopathy (AE) is a generic term that is often used to describe a diffuse cerebral abnormality. There are multiple etiologies for AEs, including metabolic, iatrogenic and toxic, infectious, primary neurologic, surgery-related, and others 1 . The main clinical feature of AEs is an altered state of consciousness that may range from minimally reduced wakefulness or awareness to coma 1, 2 . Patients with this condition are frequently present in hospitals of any size, and their mana gement requires a precise etiological diagnosis.
Although less attention has been paid to the EEG features characteristic of AEs compared to others such as epileptiform activity, seizures and status epilepticus, the usefulness of EEG in the evaluation of abnormal states of consciousness has been demonstrated 3 . It is well established that the amplitude and frequency of brain waves, or oscillations, that result from neural activity, and the particular patterns of the EEG, are closely correlated with the level of consciousness and with a deepening of coma 2, 4 . EEG is most helpful in the diagnosis of non-convulsive status epilepticus (NCSE) and in conditions such as hepatic encephalopathy or other metabolic disorders that can manifest with certain patterns such as triphasic waves 5, 6 . EEG is also useful in prognostic evaluation. For example, EEG patterns such as burst-suppression have been associated with the highest mortality rates 7 . One common finding in patients with AEs is a diffuse slowing of oscillatory brain activity, an abnormality that is always present in metabolic coma 4 . When this pattern occurs in patients with subtle abnormalities of conscience, the differentiation between diffuse slowing and somnolence may be difficult 8 . Diffuse slowing may be both qualitatively and quantitatively assessed, and has a high degree of correlation with prognosis, particularly when the patient's etiology includes cardiorespiratory arrest 4, 9 . The progressive use of EEG in the emergency room and in the intensive care unit (sometimes with continuous monitoring) has expanded rapidly in the past several years. Thus, there is a need to increase our understanding of correlations that may exist between the EEG abnormalities observed in AEs and the clinical and laboratory features of these pathologies, including the prognosis of the patient 3 . The objective of the present work is to investigate qualitative and quantitative EEG patterns in patients with AEs and background abnormalities independently of disease etiology.
METHOD
The current study reviewed all the urgent EEGs performed in a one year interval as well as the medical records of the patients involved. Exams were performed in the EEG laboratory using a 22 channel recorder (Meditron; São Paulo, Brazil) following the 10-20 international system of electrode placement, including photic-stimulation and 20 to 30 minutes extent. The sampling rate used was 200 Hz, and all electrode impedance was kept below 10 KΩ. This study was approved by the local Ethics Committee. The criteria for patient inclusion were: a diagnosis of AE defined as any abnormality of conscience continuing until the time of EEG evaluation, EEG and medical records that were available for review, EEGs showing background abnormalities characterized mainly by diffuse slow theta and delta waves, and no use of sedative medications for at least 24 hours prior to the EEG. Patients with clear symptoms of somnolence and/or with physiologic sleep patterns, who had been evaluated for brain death, who had a coma diagnosis or more specific EEG abnormalities such as triphasic waves, periodic discharges, NCSE, coma patterns (alpha, theta and spindle), burst suppression, or others were excluded from this investigation.
Patients were clinically classified into three main categories according to previously described definitions: clouding of consciousness (minimally reduced wakefulness or awareness), obtundation (mild to moderate reduction in alertness), and stupor (able to be aroused only with vigorous and continuous stimulation) 2 
.
Patients were divided into two groups: Group A patients had a favorable outcome (hospital discharge), and Group B patients had an unfavorable outcome (death).
Qualitative EEG analysis
All records included in this study were visually analy zed by one rater who was unaware of the clinical data. Exams were classified into 5 grades: 0-normal; 1-normal -limit (unstable or suppressed alpha rhythm frequently replaced by a high prevalence of diffuse beta rhythm); 2-mild signs of encephalopathy (low frequency alpha rhythm disturbed by random waves in the theta range over both hemispheres); 3-distinctive features of encephalopathy (background acti vity in the theta range, diffused over both hemispheres, and the random appearance of high amplitude waves in the delta range); 4-signs of severe encephalopathy (severe disorganization of EEG activity with no normal elements; having diffuse asynchronous theta and delta waves over both hemispheres) 10 .
Quantitative EEG analysis
To perform the qEEG analysis, the EEGLAB version 9 (http://www.sccn.ucsd.edu/eeglab) software running under Matlab R2010a (MathWorks; Natick, USA) was used 11 . Twenty electrodes were used for this evaluation (Fp1, Fp2, F7, F3, Fz, F4, F8, T3, C3, Cz, C4, T4, T5, P3, Pz, P4, T6, O1, Oz, and O2) with linked A1 and A2 as references. All exams were subjected to the same pre-processing steps. First, exams were converted to European Data Format (EDF) and imported into the software. Then, the exams were filtered using a 0.5 Hz (low) and 50 Hz (high) cutoff frequency. Each exam was then submitted to artifact rejection by visual analysis. The localization of electrode coordinates were determined and corrected if necessary. Exams were then decomposed using independent component analysis 11 . Independent components were used for artifact rejection and for statistical analysis. Finally, for each participant, channel spectra and associated topographical maps were plotted using the fast Fourier transform. This generated data represents the whole record (20 to 30 minutes) within the frequencies of 2 and 24 Hz, with emphasis in the alpha range (8) (9) (10) (11) (12) .
To perform the quantitative evaluation, a statistical analysis was conducted that compared the EEG power spectrum and scalp maps of patients in Group A versus Group B using EEGLAB software. A cluster approach was also conducted to reinforce the statistical analysis. Independent components from each dataset were identified and grouped based on the mean of the scalp maps and power spectrum using principal component analysis 12 . Finally, a k-means algorithm was used to generate the clusters 12, 13 . Comparisons were performed using a permutation test with 5000 permutations and the level of significance was set at p<0.05.
Statistical analysis
Clinical differences including age, number of comorbidities, etiology, and clinical features were compared between Groups A and B. Qualitative EEG findings were also compared between the two groups. In the statistical analysis, we used Fisher's exact test to evaluate proportions, and the Mann-Whitney non-parametric test for means comparisons.
RESULTS

Clinical features
Group A consisted of 43 patients (20 women, mean age 57±23 years, range 18 -93). The mean number of comorbidities was 2±1 (range 0 -7). Ten patients in Group A were diagnosed with structural encephalopathy secondary to cerebrovascular disease, eight patients had metabolic disorders, six patients had systemic infectious diseases, six patients had epilepsy decompensated by infectious diseases, five patients had infections of the central nervous system, two patients had eclampsia, two patients had autoimmune encephalitis, two patients presented with traumatic brain injury, and two patients had hypoxia secondary to cardiac abnormalities. Group B consisted of five patients (two women, mean age 63±13 years, range 48 -83). The mean number of comorbidities was 4±1 (range 3 -5). All patients presented with systemic infectious diseases. Statistical analysis did not show significant differences between the two groups in terms of age (p=0.7, U=95.5). The number of comorbidities was higher in Group B patients (p=0.02, U=42).
Analysis of clinical features showed that 27 patients presented with clouding of consciousness, 10 with obtundation, and six with stupor in Group A. In Group B, two patients presented with clouding of consciousness and three with stupor. Group B contained a higher proportion of patients with a more severe clinical picture characterized by stupor (p=0.04).
Since all patients in group B had systemic infectious diseases, a comparison with six patients (two women, mean age 64±28 years, range 18 -93) in group A with the same diagnosis was conducted. The mean number of comorbidities was 1±0.8 (range 1 -3). Two patients presented with a clouding of consciousness, two with obtundation, and two with stupor. Compared with group B, statistical analysis showed difference only in the number of comorbidities (p=0.01, U=1).
Qualitative EEG analysis
In Group A, seven (16%) exams were rated as Grade 1 (unstable or suppressed alpha rhythm frequently replaced by a high prevalence of diffuse beta rhythm), 14 (32%) as Grade 2 (low frequency alpha rhythm disturbed by random waves in the theta range over both hemispheres), 15 (35%) as Grade 3 (background activity in the theta range, diffused over both hemispheres, and the random appearance of high amplitude waves in the delta range) and 7 (16%) as Grade 4 (severe disorganization of EEG activity with no normal elements; having diffuse asynchronous theta and delta waves over both hemispheres) 10 . Group B had a higher proportion of exams that were rated as Grade 4 (5 EEGs, 100%, p<0.001). Figure 1 shows examples of the four grades of EEG exams.
In the patients of group A with systemic infectious diseases two EEGs were rated as Grade 2, two as Grade 3 and two as Grade 4. No statistical difference was observed when compared to group B (p=0.5).
Quantitative EEG analysis
The visual evaluation of the spectral EEG data showed that, in Group A, 84% (36/43) of the patients had anterior-posterior differentiation signs and spectral peaks in the theta and alpha bands (Figure 2A) . In Group B, a spectral peak in the delta band was detected in one patient, and the remainder of the patients in both groups did not present spectral peaks ( Figure 2B ).
Statistical analysis confirmed the observations described above. Comparisons between the two groups revealed that the main differences consisted of lower frequencies in the posterior electrodes and reduced power spectrum in the Group B patients, compared to Group A ( Figure 3A and Bsuperior row, Figure 4A ).
Evaluating the patients of group A with systemic infectious diseases, spectral peaks in theta and alpha bands were present in 83% (5/6). Results of statistical comparisons with group B were similar to the whole group analysis. Spectral scalp maps of patients in this subgroup were more physiolo gical and permutation analysis showed statistical differences in two central and one posterior electrode ( Figure 3A and B -inferior row). Reduced power spectrum was also observed with the main differences occurring between 6 and 10Hz ( Figure 4B ).
DISCUSSION
The current investigation revealed two important findings. First, patients with AEs and poor outcome have distinct EEG patterns that are characterized by signs of severe encephalopathy. Although EEG has long been recognized as a useful prognostic tool, our study highlights that, in a general hospital setting with patients having pathologies of varied etiology, the EEG is a very useful complementary diagnostic tool. A second important result of the current work is a mapping of the quantitative abnormalities in two groups of AEs patients. Patients having a poor prognosis did not present with a physiological anterior posterior gradient on the EEG. In addition, we found an overall slowing of EEG frequencies in patients with a poor prognosis.
Given that the etiology of the AE may affect the EEG differently, a second comparison between patients with the same diagnosis in both groups was performed. The results were similar to the whole group analysis. The comparison of the scalp maps of subgroup A (only patients with systemic infectious diseases) with group B showed differences only in two central and one posterior electrode ( Figure 3B ). However, the scalp maps are very similar showing a higher frequency in the group A in both analyses ( Figure 3) . Evaluation of the clustered independent components showed a better defined spectral peak in the subgroup A. Statistical analysis also showed main significance differences in the 6-10Hz range ( Figure 4 ). It is important to observe that qualitative analysis did not show differences between these groups. Clinical evaluations of the AEs patients in the current study revealed a higher mortality in patients who had an elevated number of comorbidities. Interestingly, the average age of the patients did not differ between the groups. However, as the number of previous diseases naturally increases with age, mortality is most likely higher in older patients. The small number of patients in Group B likely contributed to this lack of difference. Different etiologies, as one would expect to find in a general hospital setting, contributed to the cause of the AEs in these patients. The etiologies reported in the two groups were similar to those observed in a previous investigation, with the exception of dementia and learning disabilities that were not observed in the current study 14 . Dementia and learning disabilities were the main underlying cause of the AEs observed amongst a previous investigation of 123 patients 14 .
One interesting finding from the current study is that all patients of Group B presented with toxic encephalopathies secondary to systemic infectious diseases. Evolution, or some degree of sepsis, contributed to this elevated mortality. Sepsis is often accompanied by an acute deterioration of mental status. The underlying mechanism of this is highly complex, and results from both inflammatory and non-inflammatory processes that induce blood-brain barrier breakdown, dysfunction of intracellular metabolism, neural cell death, and brain injuries. Sepsis-associated encephalopathy is accompanied by EEG abnormalities, and EEG exams are usually required in the presence of seizure and when encephalopathy remains unexplained 15 . Our results also suggest that the increasing use of qEEG in the context of sepsis related AEs could be useful in determining the severity and prognosis of this condition, as well as directing treatment goals. In addition, a previous investigation using this same group of patients demonstrated that the severity of EEG abnormalities has a clear relation with patient mortality 16 . The current study has several drawbacks. One important limitation is that, the number of patients in group B was small. This difference may have introduced a bias in the statistical analysis. The groups also significantly differ in non-EEG parameters (comorbidities, etiology, and level of consciousness), and these likely are confounding factors with regard to outcome. Therefore, these limitations have to be considered when interpreting the results. Another important problem is that, while EEG has an excellent temporal resolution, it usually provides only a brief snapshot of brain activity, which may or may not be characteristic. Thus, a single recording is not the gold standard method for the evaluation of patients with abnormalities of consciousness, and an investigation using serial or continuous EEG monitoring would be more informative. Despite of these problems, in the current investigation, which was centered upon the detection of background abnormalities, the one-time recording paradigm was useful. Therefore, the value of a single EEG recording may not be diminished, especially when severe background abnormalities are present.
The objective of qEEG is to improve the detection of abnormalities in brain activity. In this study, the visual analysis of EEG traces showed similar results to the quantitative analysis. However, the main purpose of using qEEG in this investigation was to allow the comparison of EEGs between the two groups. Quantitative EEG has the advantage of not being user-dependent, thus the investigator bias is reduced. The quantitative analysis is informative because the whole EEG recording may be condensed into a single graphic, which is helpful for the interpretation of the exam by non-specialists. In addition, a key point of the qEEG is that differences between groups may be detected with more precision, as demonstrated in the current work.
Finally, the use of EEG must be routine in all patients with suspected AEs. This exam is useful not only for etiological diagnosis but also for the quantification of the severity of the AE. Older patients diagnosed with an AE with multiple comorbidities, particularly systemic infections, must be treated with intensive care, especially if the EEG shows signs of severe encephalopathy.
